title: [Nuclear export inhibitors as a potential therapy for multiple sclerosis].
authors.affiliation: Department of medicine/clinical immunology, the immunology institute, Icahn school of medicine at Mount Sinai, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, box 1089, 10029 New York, NY, États-Unis.
authors.forename: Olivier
authors.initials: O
authors.lastname: Herbin
authors.affiliation: Department of neuroscience, Icahn school of medicine at Mount Sinai, New York, NY, États-Unis.
authors.forename: Jeffery D
authors.initials: JD
authors.lastname: Haines
mesh_terms: D021581:Active Transport, Cell Nucleus / Q000187:drug effects*; D002467:Cell Nucleus / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D056747:Immunomodulation / Q000187:drug effects; D028884:Karyopherins / Q000037:antagonists & inhibitors*; D058990:Molecular Targeted Therapy / Q000379:methods*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000378:metabolism; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018160:Receptors, Cytoplasmic and Nuclear / Q000037:antagonists & inhibitors*; D055815:Young Adult; D000097606:Exportin 1 Protein
chemical_list: D028884:Karyopherins; D018696:Neuroprotective Agents; D018160:Receptors, Cytoplasmic and Nuclear; D000097606:Exportin 1 Protein